NCT05112627View on ClinicalTrials.gov

Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy

CompletedOBSERVATIONAL

Enrollment

15

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

May 15, 2024

Study Completion Date

May 15, 2024

Conditions

Metastatic Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v8

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood collection

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Mayo Clinic

OTHER